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Several theories have been advanced to account
for the development of varices in the superficial veins
of the lower extremity. The most widely held belief
is that valvular incompetence in the greater saphe-
nous vein results in venous hypertension and even-
tual dilatation,1 and the near-constant association of
saphenous incompetence with varicose disease
appears to support this hypothesis. Other theories
implicating hemodynamic stress in the development
of varicose veins include the presence of abnormal
arteriovenous communications resulting in venous
hypertension2 and excessive turbulence due to dilat-
ed vasa vasorum.3 Finally, primary disease of the vein
wall, in particular with regard to connective tissue
metabolism, has been postulated to lead to varicose
degeneration.4 Although circumstantial evidence
supporting these theories has been reported, there is
a paucity of direct evidence to support them.
The collagen content in varicose veins is in-
creased.5 Histologic studies have revealed an accumu-
lation of connective tissue within the muscle layers of
varicose veins, with disruption of the muscular bun-
dles.6,7 Smooth muscle cells in varicose veins have
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Purpose: The goal of the present study was to examine the role of matrix metallopro-
teinase (MMP) activity in the development of varicose changes in the superficial veins of
the lower extremity. 
Methods: Normal-caliber vein segments from the saphenofemoral junction were harvest-
ed from patients undergoing saphenous vein ligation for varices and from patients
undergoing infrainguinal bypass graft procedures. The activity and quantity of MMPs
and their inhibitors (tissue inhibitors of metalloproteinases [TIMPs]) in the vein seg-
ments were compared. Vein segments were obtained from 13 patients. Seven patients
had varicose disease in the leg, including 6 women and 1 man (average age, 48 years).
Six patients had no evidence of varicose disease, including 2 women and 4 men (average
age, 59 years). Proteolytic activity was determined with substrate gel zymography, and
enzyme content was determined with Western immunoblotting using monoclonal anti-
bodies directed against MMP-2, MMP-3, MMP-9, TIMP-1, TIMP-2, and a 2-
macroglobulin. Signals were quantified by scanning densitometry and normalized to a
positive control (densitometric index [DI]). Immunohistochemistry was performed for
enzyme localization. 
Results: Zymography did not detect a difference between groups at loci consistent with
the major MMPs; however, a small but significant decrease in proteolytic activity was
noted in veins from patients with varices. TIMP-1 is increased in vein segments from
patients with varices (DI 0.8 ± 0.1 vs 0.2 ± 0.05, P < .05) while MMP-2 levels were
decreased (DI 1.5 ± 0.3 vs 0.5 ± 0.1, P < .05). Immunohistochemistry localized MMPs
to the adventitia of the vein wall. 
Conclusion: A decrease in proteolytic activity may be responsible for the histological and
structural alterations leading to varicose degeneration of superficial lower extremity
veins. (J Vasc Surg 1998;28:669-75.)
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been noted to contain vacuoles of degraded collagen
fibrils, suggesting that these cells contribute to the
metabolism of collagen and to the structural alter-
ations noted in varicose disease.4 Conversely, the
elastin content of varicose veins is decreased com-
pared with normal veins. Morphometric studies both
in vitro and in vivo have demonstrated a decrease in
the elastic properties of varicose veins and suggest that
abnormalities of the vein wall precede valvular incom-
petence in the pathogenesis of varicose veins.8,9
Enzymatic activity in vein walls has been studied
with respect to tissue remodeling. Decreases in the
fibrinolytic activity of calf veins have been reported,
whereas an increase in tissue plasminogen activator
in the region of the groin has been noted.10 Elastase
activity, however, was not different between normal
and varicose veins in a study by Gandhi et al,5 lead-
ing these investigators to exclude enzymatic matrix
degradation in the etiology of varicose veins.
However, the activity of metalloproteinases (prote-
olytic enzymes essential in the breakdown and
remodeling of connective tissue) in varicose veins
has not been investigated. The purpose of this study
was to evaluate the proteolytic activity and expres-
sion of matrix metalloproteinases (MMPs) in veins
from normal patients and patients with lower
extremity varicose veins to elucidate the role of these
enzymes in the development of varices. 
METHODS
Patients and vein samples. After this protocol
was approved by the Human Research Committee at
our institution, small portions of saphenous vein
without obvious varicose changes were collected
from the saphenofemoral junction of 13 patients.
Seven patients had vein stripping for symptomatic
varicose disease located in the distal extremity,
including 6 women and 1 man (average age, 48
years). Of these patients, 4 had preoperative duplex
examination demonstrating incompetence of the
greater saphenous vein at the level of the groin in 3.
There was no evidence of arterial insufficiency in any
of the patients with varices, none of these patients
had diabetes, 1 had a history of coronary artery dis-
ease, and 5 had a history of tobacco abuse. 
Among the 6 patients who had vein harvested
for bypass of infrainguinal occlusive disease, there
were 2 women and 4 men (average age, 59 years).
There was no evidence of varicose disease at opera-
tion in any of these patients, and duplex mapping of
the saphenous vein in 2 patients did not demonstrate
reflux. Bypass was performed for rest pain in 3
patients and for healing of tissue loss in 3. The
ankle-brachial index was 0.4 or less in 4 patients and
was not able to be obtained because of calcific tibial
artery disease in the remaining 2. Risk factors for
coronary artery disease were more common in this
group and included a history of diabetes in all 6
patients, coronary artery disease in 4 patients, and
tobacco abuse in 5 patients. 
Protein preparation. Tissue specimens were
frozen in liquid nitrogen at the time of the harvest
and placed at –80°C. For analysis, 100-mg to 500-
mg pieces of vein wall were thawed and gently agi-
tated in phosphate-buffered saline (PBS) to remove
residual blood. A 3-mm segment of vein was taken
from the specimen and flash-frozen in OCT mount-
ing solution for histological evaluation. All manipu-
lations were done at 4°C to prevent protein degra-
dation. The remaining samples were minced, flash-
frozen in liquid nitrogen, and pulverized to a fine
powder. The powdered vein wall then was resus-
pended in a 2 mol/L sodium chloride/0.05 mol/L
Tris/0.1% Brij 35 (v/v) solution at pH 7.5 (0.2 mL
of buffer, 100-mg sample). The samples were then
centrifuged at 10,000 g at 4°C for 1 hour, the super-
natant was collected, and protein concentrations
were determined according to the method of
Bradford.11 
As recommended by the manufacturer of the
antibodies used in this study, conditioned media
from human fibrosarcoma cells (HT-1080; American
Type Culture Collection, Rockville, Md) was used
for a positive control. The cells were grown in an
enriched media (10% fetal calf serum) to confluence
and then were stimulated with phenyl methyl acetate
(100 nmol/L) in minimal media. After 2 hours, the
media were collected and concentrated. Protein con-
centrations were obtained using the method of
Bradford, and the concentrated media were used as
the positive control in both Western blotting and
zymography.
Substrate zymography. Gelatin substrate zymo-
grams were prepared by adding Type B bovine gelatin
(Sigma, St. Louis, Mo) to a 10% sodium dodecyl sul-
fate-polyacrylamide gel at a final concentration of 1
mg/mL.12 Twenty-microgram protein samples were
electrophoretically separated using a minigel appara-
tus (BioRad, Hercules, Calif) under nonreducing
conditions. Both Kaleidoscope and molecular weight
size markers were used as standards (BioRad). The
gels then were washed in 2.5% Triton X-100/50
mmol/L Tris solution twice for 20 minutes, followed
by three 5-minute washes with a 50 mmol/L Tris/10
mmol/L CaCl/0.02% sodium azide, pH 7.8, solu-
tion. The gels then were incubated in the Tris-CaCl
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buffer at 37°C for 16 hours, stained in Coomassie
blue for 5 to 20 minutes, and destained with
methanol. Zones of lysis were quantified with a scan-
ning densitometer (Molecular Dynamics, Sunnyvale,
Calif) and normalized to the HT-1080 digestion to
compensate for gel-to-gel staining differences. Values
are reported as the ratio between the actual value to
the positive control (densitometric index [DI]).
Kilodalton weight estimates were obtained using
ImageFragment Software (Molecular Dynamics) and
the molecular weight standards.
Western analysis. For Western immunoblot-
ting, samples were prepared as above and elec-
trophoretically separated onto standard 10% poly-
acrylamide Laemmli gels.13 To correspond to the
zymograms, all immunoblots were run under non-
denaturing conditions. In addition, blots for MMP-
2 and MMP-9 were separated under denaturing
conditions as well. Monoclonal mouse anti-human
antibodies to MMP-2, MMP-3, and MMP-9, tissue
inhibitors of metalloproteinases (TIMP-1 and
TIMP-2), and a 2-macroglobulin were used as pri-
mary antibodies (Oncogene Science, Cambridge,
Mass). Antibody binding was linear as confirmed in
preliminary slot blot experiments using protein from
both cell culture supernates and tissue specimens.
Goat anti-mouse horseradish peroxidase-coupled
antibodies were used as the secondary antibody
(BioRad). Signal detection was performed using the
Renaissance chemiluminescence kit (New England
Nuclear, Boston, Mass) according to the manufac-
turer’s instructions. Autoradiographs of the blots
were obtained and subsequently analyzed using the
densitometer as described above. 
Immunohistochemistry. Immunohistochemistry
was performed on 8-µm sections of vein as described
previously.14 Slides were initially washed in 0.1
mol/L PBS for 5 minutes followed by 2 3-minute
washes in 0.05% borohydride in 0.1 mol/L PBS, fin-
ishing with a 5-minute wash in 0.3% Triton X-100 in
0.1 mmol/L PBS. Slides were again washed for 5
minutes in 0.3% Triton X-100 followed by a 2-hour
incubation with the primary antibody in blocking
solution (10% goat serum and 0.4 g of bovine serum
albumin in 0.3% Triton X-100/PBS). Primary anti-
bodies to MMP-2, MMP-9, and TIMP-1 were used.
Slides were washed in 0.3% Triton X-100 and then
incubated with indocarbocyanine-3-labeled goat anti-
mouse IgG secondary antibody in blocking solution
for 1 hour, followed by a series of washes: 5 minutes
in 0.3% Triton X-100, twice for 2 minutes in 0.06%
Triton X-100, and twice for 2 minutes in 0.1 mol/L
PBS. Slides were then air dried and coverslip mount-
ed with one drop of 50% glycerol. Specimens then
were examined at 100· magnification using a fluores-
cent lens mounted on a Zeiss microscope. For quan-
titative analysis, images from the center of the 
vein wall were obtained in four different quadrants
and were transferred to computer using a video cam-
era where the fluorescence was quantified using
MetaMorph software (Universal Imaging Co, West
Chester, Penn). In addition, full wall images including
lumens were obtained of specimens exposed to anti-
MMP-9 antibodies (qualitative analysis). The 8-µm
sections were also stained with both hematoxylin and
eosin and trichrome stains.
Statistical analysis. All numeric data are
reported as mean ± the standard error of the mean.
Student’s t test was used to compare densitometric
indexes between patients with and without varicose
veins, and the Fisher’s exact test statistic was used to
compare categorical data.
RESULTS 
No significant differences in either age or gender
distribution between patients with and without vari-
cosities was identified. 
Zymograms of vein protein homogenates
demonstrated four discernible levels of proteolytic
digestion. There was no difference in proteolytic
activity between the samples from patients with and
without varices at the three most prominent bands
between 66 and 96 kDa. There was a significant
decrease in proteolytic activity in veins from patients
with varices at 59 kDa, although the least amount of
proteolytic activity was noted at this level. The DI at
this level for veins from patients without varicose
changes was 1.97 ± 0.10 compared with 2.19 ± 0.03
in samples from patients with varices (P < .05). 
Western immunoblots showed a significant
decrease in MMP-2 immunoreactive protein content
in veins from patients with varices, with a DI of 0.5
± 0.1 versus 1.5 ± 0.3 in veins from patients without
varices (P < .05; Fig 1). Conversely, immunoreactive
TIMP-1 was significantly increased in veins from
patients with varices (DI, 0.8 ± 0.1) compared with
samples from patients without varices (DI, 0.2 ±
0.05, P < .05; Fig 2). There was no significant dif-
ference in immunoreactive protein between the two
groups for MMP-3, MMP-9, a 2-macroglobulin,
and TIMP-2.
Trichrome staining identified an increase in col-
lagen deposition coupled with smooth muscle disor-
ganization in sections from patients with distal vari-
cose veins (Fig 3A, 3B). Qualitative analysis of
immunohistochemistry preparations showed metal-
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loproteinase localization to the outer media and
adventitia (Fig 3C, 3D). Quantitative analysis, how-
ever, did not reveal significant differences in
immunohistochemical staining for MMP-2, MMP-
9, and TIMP-1 between the specimens from patients
with and without varices. 
DISCUSSION
We demonstrated decreased immunoreactive
MMP-2 protein and increased immunoreactive
TIMP-1 protein in normal-appearing segments of the
greater saphenous vein from patients with varicosities
in the leg. Major differences in proteolytic activity
were not detected between our study groups; howev-
er, a decrease in gelatinolytic activity was noted in the
veins from patients with varices at 59 kDa, where the
least amount of proteolytic activity was detected.
Immunohistochemistry localized the enzymes of the
metalloproteinase family to the adventitia, whereas
the media was relatively devoid of these enzymes. 
Our findings support recent suggestions that
biochemical alterations of the vein wall accompany
the development of varicosities. Shireman et al10
reported an increase in urokinase-type plasminogen
activator in varicose greater saphenous veins com-
pared with normal veins and also noted an increase
in tissue plasminogen activator at the level of the
groin compared with the ankle. Because these acti-
vators of the plasmin fibrinolytic cascade may in turn
activate latent MMPs, one might expect an increase
in proteolytic activity at the saphenofemoral junc-
tion of patients with varicose veins. 
Other circumstantial evidence support a prote-
olytic etiology of varicose veins. One report has
shown a decrease in elastin and collagen content in
varicose veins15; histologic evaluation has shown an
increase in the deposition of degraded collagen, with
disruption of the muscular bundles6,7; and ultra-
structural examination has revealed fragmented col-
lagen fibrils within medial smooth muscle cells,
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Fig 1. Representative immunoblot using primary anti-
body to MMP-2. Lane A, 20 µg of conditioned media
from HT-1080 cells (positive control). Lane B, 20 µg of
protein homogenate from patient without varices. Lane C,
20 µg of protein homogenate from patient with varicosi-
ties. Signal noted at approximately 66 kDa is consistent
with MMP-2 and was decreased in the samples from
patients with varicose disease.
Fig 2. Representative immunoblot using primary anti-
body to TIMP-1. Lane A, 20 µg of conditioned media
from HT-1080 cells (positive control). Lane B, 20 µg of
protein homogenate from patient without varices. Lane C,
20 µg of protein homogenate from patient with varicosi-
ties. Signal noted at approximately 29 kDa is consistent
with TIMP-1 and was increased in samples from patients
with varicose disease.
implying that these cells are active in the reorganiza-
tion of structural proteins in the vein wall.4 These
findings correlate with the morphometric data of
Bocking and Roach,9 who noted an increased dis-
tensibility of saphenous veins from patients with
varicosities, and Clarke et al,8 who found a signifi-
cant reduction in vein wall elasticity in patients at
high risk for the development of varicosities before
the development of valvular incompetence. Lowell
et al16 noted a decrease in contractile capability of
saphenous veins from patients with varicosities dis-
tally. Increased proteolytic activity of the vein wall
could account for many of these findings. 
However, we and others have been unable to
demonstrate an increase in proteolytic activity within
the walls of varicose veins. We did note a small but sig-
nificant decrease in proteolytic activity in veins from
patients with varices at 59 kDa, which may be due to
activity of latent MMP-1 as noted by other investiga-
tors.17 There was no significant difference in the
majority of proteolytic activity that occurred at 66 and
84 kDa (corresponding to MMP-2 and MMP-9,
respectively) on our zymograms. This agrees with the
findings of Gandhi et al,5 who were unable to detect a
difference in proteolysis either by substrate zymogra-
phy or radiolabeled substrate assay. Moreover, we
detected a decrease in MMP-2 and an increase in
TIMP-1 immunoreactive protein in specimens from
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Fig 3. Photomicrographs and immunohistochemistry (magnification, 100 · ) of vein sections. L,
Region of the lumen. A, Trichrome-stained section of saphenous vein near the groin from patient
without varices. The media is composed entirely of well-organized smooth muscle cells. 
B, Trichrome-stained section of saphenous vein near the groin from patient with varices located
lower in the leg. The media is infiltrated with collagen, and the smooth muscle architecture is dis-
rupted. C, Immunohistochemical stain using monoclonal antibody for MMP-9 in section from
patient without varices. Positive staining is noted only in adventitial and perivascular region. A
paucity of staining is noted in the media. D, Immunohistochemical stain using monoclonal anti-
body for MMP-9 in section from patient with varices. A similar but less intense pattern of posi-
tive staining is noted compared with c despite infiltration of the media with collagen. Similar pat-
terns of staining were noted with MMP-2 and TIMP-1 antibodies (data not shown).
patients with varicosities; a finding that implies a pre-
disposition toward decreased proteolysis in veins pre-
disposed to varices compared with normal veins. A
deficiency in proteolytic activity would also be consis-
tent with the biochemical, histological, and ultrastruc-
tural changes noted above. Collagen deposition in the
walls of varicose veins may result from the inability of
the vein wall to completely degrade this extracellular
matrix protein, predisposing the vein, leading to the
morphometric and vasomotor changes noted.
Immunohistochemical analysis of our specimens
localized the enzymes of the metalloproteinase family
to the adventitia. This is consistent with the findings of
Hach et al,18 who noted a localization of fibrinolytic
activity to the adventitia of normal and varicose veins,
and with those of Newman et al,19 who noted adven-
titial metalloproteinase expression in aortic aneurysms.
In addition, Yamada et al20 demonstrated clusters of
mast cells in the adventitia, which may be a source for
MMP protein.19,20 However, George et al21 did note
the presence of MMP mRNA and protein in endothe-
lial as well as adventitial microvascular endothelial cells.
Although we used more specific antibodies in our
study, we may have been unable to detect endothelial
staining because of preparation artifact. In any event,
both our study and that of George et al21 confirm the
paucity of MMP enzymes in the medial layers of nor-
mal and varicose veins.
Our study compared vein specimens of normal
caliber obtained from patients with arterial insuffi-
ciency in the leg with those obtained from patients
with distal varicose veins. The differences we
observed between the two groups confirm the pres-
ence of metabolic alterations in the vein wall and
suggest that these processes affect the entire vein.
This study, however, has several limitations. Patients
with chronic lower extremity ischemia may not rep-
resent the population at large with normal saphe-
nous veins, and our findings may represent changes
unique to this group of patients. This seems unlike-
ly, however, given the excellent data available on the
preoperative evaluation of the saphenous vein in
patients with lower extremity ischemia. Veith et al22
noted a subclinical presence of varices in only 5% of
extremities studied with venography, and none of
our patients were noted to have varices at operation.
We did not study actual varicosities because spec-
imens from stab avulsion of varicose veins are usually
damaged to the extent of compromising valid analy-
ses. Rather, we examined saphenofemoral segments
above the areas of varicose disease and have inferred
that the alterations observed predispose to varicose
degeneration. This inference is supported by the
results of the study of Gandhi et al,5 who noted sim-
ilar connective tissue content and proteolytic activity
in potential varicose veins (analogous to the speci-
mens in our study) and in the varices themselves.
Zymography has inherent limitations insofar as
activation of metalloproteinases by the sodium
dodecyl sulfate present in the polyacrylamide gel
causes falsely elevated estimates of proteolytic activi-
ty.23 Thus, subtle differences in proteolytic activity
may be undetectable and may explain our inability to
demonstrate a decrease in proteolysis in veins from
patients with varices despite an increase in immuno-
reactive MMP-2. Although the populations from
which we obtained specimens were somewhat differ-
ent, statistical analysis did not demonstrate a differ-
ence in age or gender distribution between our
groups. Furthermore, both groups had a predomi-
nance of smokers, and the influence of tobacco use
on our results cannot be determined. 
We demonstrated alterations in metallopro-
teinase quantity and, to a lesser extent, activity in
normal-appearing segments of saphenous vein from
patients with varices. Decreased MMP-2 and
increased TIMP-1 protein may establish an antipro-
teolytic milieu conducive to increased collagen
deposition and eventual varicose degeneration.
Further studies are needed to evaluate this process. 
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